Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: Therapy of Steroid-Refractory Chronic GVHD with Subcutaneous Low-Dose Alemtuzumab and Rituximab Combination Is Effective and Safe, Biology of Blood and Marrow Transplantation, February 2012, Elsevier,
DOI: 10.1016/j.bbmt.2011.12.432.
You can read the full text:
Contributors
The following have contributed to this page
